Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Gapping up/down: MOMO +11%, PIR +3%, and PRTS +2% after earnings/guidance, NMBL +45% and GLBL +17% after M&A news; CASY -6%, THO -4%, NAV -3%, ASNA -2% and DKS -2% after earnings<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>MLNK</strong> +25.5%, <strong>MEET</strong> +23.3%, <strong>HPJ</strong> +20%, <strong>ETRM</strong> +14.5%, <strong>MOMO</strong> +10.5%, <strong>JNP</strong> +9.9%, <strong>MIK</strong> +7.1%, <strong>ADUS</strong> +6.4%</li><li><strong>ATSG</strong> +3.6%, <strong>WMC</strong> +3.6%, <strong>PIR</strong> +3.2%, (guides for Q4 EPS of $0.32-$0.34 vs. $0.31 CapitalIQ Consensus; Sales decreased 2.6%)</li><li><strong>BTE</strong> +3.2%, <strong>PLOW</strong> +3.1%, <strong>PRTS</strong> +2.4%, <strong>LGIH</strong> +1.7%, <strong>AVD</strong> +1.6%, <strong>MNTX</strong> +1%, <strong>FANH</strong> +0.9%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>NMBL</strong> +45.2% (to be acquired by Hewlett Packard Enterprise (HPE) for $12.50/share in cash)</li><li><strong>GLBL</strong> +16.5% (to be acquired by Brookfield Asset management (BAM) for $787 mln in cash)</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>WFT</strong> +15.6% (appointed Mark McCollum as President and Chief Executive Officer with an effective start date in late April 2017)</li><li><strong>GMAN</strong> +15% (after closing near lower on reports that the company may be preparing a potential bankruptcy filing)</li><li><strong>VRML</strong> +9.8% (attains out-of-state provider status with Medi-Cal, California's Medicaid program, for OVA1 access to over 12 mln beneficiaries)</li><li><strong>DISH</strong> +5% ( to replace Linear Technology in S&P 500)</li><li><strong>TROV</strong> +2.8% (announces that a patient case series featuring use of its Trovera EGFR urine-based liquid biopsy test was recently published in Lung Cancer)</li><li><strong>LJPC</strong> +1.9% (insider buy disclosures, also Tang Capital Partners increases active stake)</li><li><strong>CRM</strong> +1.4% (IBM and Salesforce announce Landmark Global Strategic Partnership)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>SRCL</strong> +1.4% (upgraded to Neutral from Sell at Goldman)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>KTWO</strong> -8%, <strong>CASY</strong> -5.5%, (also announces $300 mln share repurchase)</li><li><strong>LPCN</strong> -4.6%, (also entered into a Controlled Equity Offering with Cantor — may offer and sell shares of common stock having an aggregate offering price of up to $20 mln)</li><li><strong>AKBA</strong> -4.4%, <strong>ALOG</strong> -4.2%, <strong>THO</strong> -3.8%, <strong>KLXI</strong> -3.5%, <strong>NAV</strong> -2.9%, <strong>DAVE</strong> -2.7%, <strong>KFY</strong> -2.7%, <strong>ASNA</strong> -2.4%, <strong>DKS</strong> -2.3%, <strong>NEWT</strong> -1%, <strong>CLLS</strong> -0.8%, <strong>AMID</strong> -0.6%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>P</strong> -3.8% (Hollywood Reporter discusses comments from Liberty Media exec who indicated that Pandora (P) is not an attractive takeover target at today's valuation), .</li></ul><p><strong>Select EU financial names showing weakness</strong>:</p><ul><li><strong>DB</strong> -1.7%, <strong>CS</strong> -0.9%, <strong>LYG</strong> -0.9%, <strong>BBVA</strong> -0.7%</li></ul><p><strong>Select metals/mining stocks trading lower</strong>:</p><ul><li><strong>DRD</strong> -2.6%, <strong>MUX</strong> -2.3%, <strong>AUY</strong> -1.6%, <strong>SBGL</strong> -1.2%, <strong>GDX</strong> -1.2%, <strong>ABX</strong> -1.1%, <strong>NEM</strong> -0.9%, <strong>AU</strong> -0.6%, <strong>HMY</strong> -0.5%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>PCRX</strong> -4.9% (announces proposed offering of $300 million aggregate principal amount of convertible senior notes)</li><li><strong>HASI</strong> -3.7% (prices 3 mln shares of common stock for proceeds of $58 mln)</li><li><strong>STAY</strong> -2.8% (prices secondary offering and repurchase of paired shares resulting in gross proceeds of $421 mln)</li><li><strong>SNAP</strong> -2.6% (continued weakness)</li><li><strong>FRC</strong> -1.6% ( agrees to sell 2,000,000 shares of its common stock in an underwritten public offering)</li><li><strong>RDHL</strong> -1% (RedHill's co-promotion partner for the gastrointestinal drug Donnatal Concordia (CXRX) announce that a U.S. district court granted a Concordia subsidiary treble damages related to false claims made by Method Pharmaceuticals and its principal owner)</li><li><strong>JBT</strong> -0.9% (announces public offering of 2 mln shares of common stock)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>FTR</strong> -2.5% (downgraded to Neutral from Buy at BofA/Merrill)</li><li><strong>NVS</strong> -1.4% (downgraded to Underperform from Neutral at Exane BNP Paribas)</li></ul></td> </tr></table>"